Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target, Experimental Hematology & Oncology

Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy: Molecular Therapy

Cancers, Free Full-Text

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies

Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?

The heightened importance of the microbiome in cancer immunotherapy: Trends in Immunology

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy - ScienceDirect

The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies, Cell & Bioscience

Frontiers Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications

Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies - Xie - iMeta - Wiley Online Library